Literature DB >> 15068804

Insights into the structure, mechanism, and regulation of scavenger mRNA decapping activity.

Meigang Gu1, Carme Fabrega, Shin-Wu Liu, Hudan Liu, Megerditch Kiledjian, Christopher D Lima.   

Abstract

Complete removal of residual N-7 guanine cap from degraded messenger RNA is necessary to prevent accumulation of intermediates that might interfere with RNA processing, export, and translation. The human scavenger decapping enzyme, DcpS, catalyzes residual cap hydrolysis following mRNA degradation, releasing N-7 methyl guanosine monophosphate and 5'-diphosphate terminated cap or mRNA products. DcpS structures bound to m(7)GpppG or m(7)GpppA reveal an asymmetric DcpS dimer that simultaneously creates an open nonproductive DcpS-cap complex and a closed productive DcpS-cap complex that alternate via 30 A domain movements. Structural and biochemical analysis suggests an autoregulatory mechanism whereby premature decapping mRNA is prevented by blocking the conformational changes that are required to form a closed productive active site capable of cap hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068804     DOI: 10.1016/s1097-2765(04)00180-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  47 in total

1.  Dynamical insight into Caenorhabditis elegans eIF4E recognition specificity for mono-and trimethylated structures of mRNA 5' cap.

Authors:  Katarzyna Ruszczyńska-Bartnik; Maciej Maciejczyk; Ryszard Stolarski
Journal:  J Mol Model       Date:  2010-06-10       Impact factor: 1.810

2.  Functional analysis of mRNA scavenger decapping enzymes.

Authors:  Shin-Wu Liu; Xinfu Jiao; Hudan Liu; Meigang Gu; Christopher D Lima; Megerditch Kiledjian
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

3.  Nematode m7GpppG and m3(2,2,7)GpppG decapping: activities in Ascaris embryos and characterization of C. elegans scavenger DcpS.

Authors:  Leah S Cohen; Claudette Mikhli; Cassandra Friedman; Marzena Jankowska-Anyszka; Janusz Stepinski; Edward Darzynkiewicz; Richard E Davis
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

4.  Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Authors:  Joanna Kowalska; Anna Wypijewska del Nogal; Zbigniew M Darzynkiewicz; Janina Buck; Corina Nicola; Andreas N Kuhn; Maciej Lukaszewicz; Joanna Zuberek; Malwina Strenkowska; Marcin Ziemniak; Maciej Maciejczyk; Elzbieta Bojarska; Robert E Rhoads; Edward Darzynkiewicz; Ugur Sahin; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2014-08-22       Impact factor: 16.971

5.  Under the Tucson sun: a meeting in the desert on mRNA decay.

Authors:  Kristian E Baker; Ciarán Condon
Journal:  RNA       Date:  2004-11       Impact factor: 4.942

6.  Decapper comes into focus.

Authors:  Vincent Shen; Megerditch Kiledjian
Journal:  Structure       Date:  2006-02       Impact factor: 5.006

7.  Mechanistic and kinetic analysis of the DcpS scavenger decapping enzyme.

Authors:  Shin-Wu Liu; Vaishnavi Rajagopal; Smita S Patel; Megerditch Kiledjian
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

8.  DcpS scavenger decapping enzyme can modulate pre-mRNA splicing.

Authors:  Vincent Shen; Hudan Liu; Shin-Wu Liu; Xinfu Jiao; Megerditch Kiledjian
Journal:  RNA       Date:  2008-04-21       Impact factor: 4.942

9.  Alteration of oligomeric state and domain architecture is essential for functional transformation between transferase and hydrolase with the same scaffold.

Authors:  Ryotaro Koike; Akinori Kidera; Motonori Ota
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

10.  eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition.

Authors:  Michael J Osborne; Laurent Volpon; Jack A Kornblatt; Biljana Culjkovic-Kraljacic; Aurélie Baguet; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.